Correlation Between Melisron and Imed Infinity

Can any of the company-specific risk be diversified away by investing in both Melisron and Imed Infinity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Melisron and Imed Infinity into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Melisron and Imed Infinity Medical Limited, you can compare the effects of market volatilities on Melisron and Imed Infinity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Melisron with a short position of Imed Infinity. Check out your portfolio center. Please also check ongoing floating volatility patterns of Melisron and Imed Infinity.

Diversification Opportunities for Melisron and Imed Infinity

-0.67

Correlation Coefficient

Melisron  Imed Infinity

Excellent diversification

The 3 months correlation between Melisron and Imed is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Melisron and Imed Infinity Medical Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Imed Infinity Medical and Melisron is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Melisron are associated (or correlated) with Imed Infinity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Imed Infinity Medical has no effect on the direction of Melisron i.e., Melisron and Imed Infinity go up and down completely randomly.

Pair Corralation between Melisron and Imed Infinity

Assuming the 90 days trading horizon Melisron is expected to generate 0.35 times more return on investment than Imed Infinity. However, Melisron is 2.83 times less risky than Imed Infinity. It trades about 0.08 of its potential returns per unit of risk. Imed Infinity Medical Limited is currently generating about 0.02 per unit of risk. If you would invest  2,289,573  in Melisron on September 30, 2024 and sell it today you would earn a total of  943,427  from holding Melisron or generate 41.21% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	99.66%
Values	Daily Returns

Melisron  vs.  Imed Infinity Medical Limited

Melisron

Risk-Adjusted Performance

17 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Melisron are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Melisron sustained solid returns over the last few months and may actually be approaching a breakup point.

Imed Infinity Medical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Imed Infinity Medical Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Imed Infinity is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Melisron and Imed Infinity

The main advantage of trading using opposite Melisron and Imed Infinity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Melisron position performs unexpectedly, Imed Infinity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Imed Infinity will offset losses from the drop in Imed Infinity's long position.

The idea behind Melisron and Imed Infinity Medical Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.